UnknownNot Applicable

Carotid Artery Stent Implantation in the Treatment of Vulnerable Plaque

China100 participantsStarted 2022-01-01

Plain-language summary

To investigate the efficacy and safety of carotid stenting for vulnerable carotid plaques. All patients with carotid artery stenosis underwent carotid arterial contrast-enhanced ultrasonography before operation. According to the examination results, they were divided into two groups: vulnerable plaque group and stable plaque group. The incidence of perioperative stroke events in the two groups was compared. The incidence of stroke events in the two groups within 1 year was compared.

Who can participate

Age range20 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patients with ischemic symptom whose carotid stenosis were more than 50% * The patients without ischemic symptom whose carotid stenosis were more than 70% Exclusion Criteria: * • Confirmed with severe intracranial vascular lesions * Suffering from the large area cerebral infarction or critical stroke sequela * Restenosis after CEA or CAS * Suffering from severe coronary heart disease, respiratory failure,the hypertension difficult to controled * Patients with malignant tumor or expected life \< 2 years

What they're measuring

Perioperative 30-day stroke rate

Timeframe: 30 days

Trial details

NCT IDNCT05524207

SponsorBeijing Tsinghua Chang Gung Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-30

Contact for this trial

keqiang zhao, M.D.

0086-56119121 zkqiang@139.com

View on ClinicalTrials.gov More Carotid Artery Plaque trials